Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02658734 |
|---|---|
| Brief Title: | A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane |
| First Submitted : | January 15, 2016 |
| First Submitted that Met QC Criteria : | January 19, 2016 |
| First Posted : | January 20, 2016 (Estimate) |
| Results First Submitted : | December 10, 2020 |
| Results First Submitted that Met QC Criteria : | January 21, 2021 |
| Results First Posted : | February 9, 2021 |
| Last Update Submitted that Met QC Criteria : | January 21, 2021 |
| Last Update Posted : | February 9, 2021 |